Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Peking University People's Hospital · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
multiple-myelomana
multiple myeloma, r2-iss stage, minimal residual disease, lenalidomide, daratumumab, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 868448
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.